Urology Doctors in Champaign, IL Accepting Medicare

5 Urology doctors found. Showing 1 - 5

Parin Patel, DO Urology Medicare: Accepting Medicare Assignments Practice Location: 3101 Fields South Dr, Champaign, IL 61822 Phone: 217-366-1240

Dr. Eric P Helfer, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3101 Fields South Dr, Champaign, IL 61822 Phone: 217-366-1240

Dr. John S. Regan, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3101 Fields South Dr, Champaign, IL 61822 Phone: 217-366-1240

Dr. John L. Newman, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 101 W University Ave, Champaign, IL 61820 Phone: 217-366-1240

Dr. Joseph A. Zalar, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 101 W University Ave, Champaign, IL 61820 Phone: 217-366-1240

News Archive

Longitudinal study finds SARS-CoV-2 neutralizing antibodies decline a year after infection

Research led by Xin Zheng of Huazhong University of Science and Technology in Wuhan, China, found that about 90% of patients who recovered from COVID-19 continued to have IgG antibodies targeting the N-domain and receptor-binding domain of the spike protein. However, approximately 43% of patients showed signs of neutralizing antibody activity.

Blueberry consumption is beneficial for hepatic diseases: Study

Conventional drugs used in the treatment of liver diseases inevitably have side effects. An increasing number of natural substances have been studied to explore if they have protective effects on the liver. Blueberries have unique effects on human retinal, brain and tumor cells, but reports about the effects of blueberries on liver diseases are lacking.

Researchers identify role of tumor-infiltrating B-cells in melanoma progression, resistance to therapy

In a multi-institutional collaborative study, scientists at The Wistar Institute and the Medical University of Vienna, Austria, have identified the role of tumor-infiltrating or tumor-associated B-cells ("TABs") in melanoma progression and resistance to targeted therapy.

Derriford Appearance Scale 24 helps identify quality-of-life issues for breast cancer patients

A new study produced by an interdisciplinary team led by Prof. Antonio Giordano, director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, tracks the development process and efficacy of the Italian translation of the Derriford Appearance Scale 24, an important clinical tool in identifying quality-of-life issues for breast cancer patients, especially concerns regarding body shame, depression, anxiety, overall appearance and appearance identity.

Study reveals changes in brain activity in response to withdrawal of life support

At a time when "donation after cardiac death" (DCD) has become an important approach to increasing the number of transplant organ donors, a provocative new study shows changes in brain activity occurring in response to withdrawal of life support, reports the May issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

Read more Medical News

› Verified 8 days ago